During a routine inspection at Rocky Mountain Cancer Centers,
Colorado License, two fetal
overexposures were identified that had not been reported to the Department.
The first case occurred on 8/23/05, and involved a PET/CT scan where the patient was injected with 16.3 mCi of FDG (F-18). After the procedure, the patient discovered she was pregnant. The fetal exposure was estimated to be 1.5 rem. The licensee determined the risk of congenital abnormalities to be negligible.
The second case occurred on 11/28/06 and also involved a PET/CT scan where the patient was injected with 11.9 mCi of FDG (F-18). After the procedure, the patient discovered she was pregnant. The fetal exposure was estimated to be 1.02 rem. The licensee determined the risk of congenital abnormalities to be negligible.
No other details are available at this time.
Additional information will be reported through
NMED as it becomes available.